Changes in the population of patients with dementia referred to Dementia disease centers in Japan as a result of the launch of Lecanemab

Early diagnosis is important for the administration of anti-amyloid-β drugs, although early diagnosis has not increased after the launch of Lecanemab. Facilitated collaboration between primary care physicians and specialists is needed to ensure that the appropriate treatment is given to the appropriate patient.